| Dr Matthew M Merz, MD | |
|
3825 Edwards Rd, Suite 300, Cincinnati, OH 45209-1287 | |
| (513) 221-1100 | |
| (513) 569-5297 |
| Full Name | Dr Matthew M Merz |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 29 Years |
| Location | 3825 Edwards Rd, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700820750 | NPI | - | NPPES |
| 2302770 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 35071144 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Fairfield Hospital | Fairfield, OH | Hospital |
| Bethesda North | Cincinnati, OH | Hospital |
| Miami Valley Hospital | Dayton, OH | Hospital |
| Christ Hospital | Cincinnati, OH | Hospital |
| West Chester Hospital | West chester, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayfield Clinic Inc | 9133013006 | 64 |
News Archive
New research suggests that neurodegenerative diseases are neither diffuse nor random but specifically target large-scale functional networks in the human brain.
A team of students at St. Louis College of Pharmacy and Washington University School of Medicine was chosen as one of three winners of the national Script Your Future Award, a national campaign to raise awareness about medication adherence.
Kyto Biopharma Inc., is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
› Verified 3 days ago
| Entity Name | Mayfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013942101 PECOS PAC ID: 9133013006 Enrollment ID: O20040211000719 |
News Archive
New research suggests that neurodegenerative diseases are neither diffuse nor random but specifically target large-scale functional networks in the human brain.
A team of students at St. Louis College of Pharmacy and Washington University School of Medicine was chosen as one of three winners of the national Script Your Future Award, a national campaign to raise awareness about medication adherence.
Kyto Biopharma Inc., is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew M Merz, MD Po Box 643398, Cincinnati, OH 45264-3398 Ph: (513) 221-1100 | Dr Matthew M Merz, MD 3825 Edwards Rd, Suite 300, Cincinnati, OH 45209-1287 Ph: (513) 221-1100 |
News Archive
New research suggests that neurodegenerative diseases are neither diffuse nor random but specifically target large-scale functional networks in the human brain.
A team of students at St. Louis College of Pharmacy and Washington University School of Medicine was chosen as one of three winners of the national Script Your Future Award, a national campaign to raise awareness about medication adherence.
Kyto Biopharma Inc., is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
› Verified 3 days ago
William Edward Walsh, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Dennis Roy Lockaby Jr., Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1400 Mallard Cove Dr, Cincinnati, OH 45246 Phone: 513-830-5014 | |
David J Kissel, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Aarti A Singla, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 E Business Way, Cincinnati, OH 45241 Phone: 513-354-3700 Fax: 513-354-3705 | |
Dr. James Michael Plunkett, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3200 Vine St, 117, Cincinnati, OH 45220 Phone: 513-475-6323 Fax: 513-487-6624 | |
Dr. Francis Clifford Valentin, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7910 Beechmont Ave, Cincinnati, OH 45255 Phone: 513-232-2663 Fax: 859-817-7848 | |
Michelle Miller, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1701 Llanfair Ave # Oh, Cincinnati, OH 45224 Phone: 513-681-4230 |